Challenges in precision medicine in pancreatic cancer: A focus in cancer stem cells and microbiota

Challenges in precision medicine in pancreatic cancer: A focus in cancer stem cells and microbiota

Pancreatic cancer adenocarcinoma (PDAC) is a lethal disease, with the lowest 5-years survival rate of all cancers due to late diagnosis. Despite the advance and success of precision oncology in gastrointestinal cancers, the frequency of molecular-informed therapy decisions in PDAC is currently negle...

Full description

Bibliographic Details
Main Authors: Catalina M. Perelló-Reus, Teresa Rubio-Tomás, Eugenia Cisneros-Barroso, Lesly Ibargüen-González, Juan José Segura-Sampedro, Rafael Morales-Soriano, Carles Barceló
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
precision medicine
PDAC
cancer stem cell
niche factors
microbiota
early diagnosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.995357/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.995357/full

Similar Items